DC.ID,SMILES_stand,InChI,SMILES,DC.NAME,NCATS.SYNONYMS,NCGC.ID,AlphaLISA.ACTIVITY,AlphaLISA.SIGNIFICANCE,logPow {predicted by ochem.eu/model/535 in Log unit},Aqueous Solubility {predicted by ochem.eu/model/536 in log(mol/L)},Label
3434.0,CCOc1ccc(N=C(C)Nc2ccc(OCC)cc2)cc1,,CCOc1ccc(N=C(C)Nc2ccc(OCC)cc2)cc1,phenacaine,Phenacaine hydrochloride,,LOW,INACTIVE,4.53,-4.81,0
1355.0,Clc1cc(Cl)c(OCC#CI)cc1Cl,,Clc1cc(Cl)c(OCC#CI)cc1Cl,haloprogin,Haloprogin,,LOW,INACTIVE,4.69,-4.78,0
2143.0,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,fenamisal,Phenyl 4-aminosalicylate,,LOW,INACTIVE,3.03,-3.12,0
,O=C1CC(c2ccccc2)Oc2ccccc21,,O=C1CC(c2ccccc2)Oc2ccccc21,,Flavanone,,LOW,INACTIVE,3.1,-4.29,0
3184.0,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,dihydroergocornine,Hydergine,,HIGH,HIGH,2.54,-3.16,1
2106.0,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,perhexiline,Perhexiline,,LOW,HIGH,5.86,-7.01,0
1037.0,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,,CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,eprosartan,Eprosartan mesylate|Eprosartan (mesylate),,LOW,INACTIVE,3.6,-4.69,0
,c1ccc(-c2nc[nH]c2-c2ccccc2)cc1,,c1ccc(-c2nc[nH]c2-c2ccccc2)cc1,,"4,5-Diphenylimidazole",,HIGH,HIGH,3.7,-3.83,1
,CCCCCCCCCCCCSCCOCCO,,CCCCCCCCCCCCSCCOCCO,,Laureth 10s,,LOW,MODERATE,6.31,-5.98,0
,CCCCCCCCCCC(CO)CCCCCCCC,,CCCCCCCCCCC(CO)CCCCCCCC,,2-Octyl-1-dodecanol,,LOW,INACTIVE,8.9,-6.99,0
,CC(=O)OCC(=O)Nc1cc(C#N)cc(NC(=O)COC(C)=O)c1Cl,,CC(=O)OCC(=O)Nc1cc(C#N)cc(NC(=O)COC(C)=O)c1Cl,,Acreozast,,LOW,INACTIVE,1.49,-3.96,0
,O=C(C=Cc1ccc(O)c(O)c1)OC(C(=O)O)C(OC(=O)C=Cc1ccc(O)c(O)c1)C(=O)O,,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,,Cichoric Acid,,MODERATE,HIGH,3.2,-4.04,1
810.0,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,deserpidine,Deserpidine,,HIGH,HIGH,4.24,-4.73,1
2757.0,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,trimetrexate,Trimetrexate,NCGC00161419-06,HIGH,HIGH,2.36,-4.08,1
,CS(=O)(=O)c1ccc(-c2nnc(C=Cc3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,,CS(=O)(=O)c1ccc(-c2nnc(/C=C/c3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,,G-007-LK,NCGC00390587-01,MODERATE,HIGH,3.69,-3.69,1
1217.0,CC1(C)OC2CC3C4CC(F)C5=CC(=O)CCC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,fludroxycortide,Flurandrenolide,,LOW,INACTIVE,2.02,-3.89,0
694.0,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,clofibrate,Clofibrate,NCGC00015257-18,LOW,INACTIVE,3.99,-3.92,0
,COc1ccc(-c2sc(NC(=O)C(C)(C)C)nc2C)cc1S(=O)(=O)Nc1ccc(O)cc1,,COc1ccc(-c2sc(NC(=O)C(C)(C)C)nc2C)cc1S(=O)(=O)Nc1ccc(O)cc1,,PI4KIIIbeta-IN-10,,HIGH,HIGH,4.42,-5.17,1
1065.0,CC12CCC3c4ccc(OC(=O)N(CCCl)CCCl)cc4CCC3C1CCC2O,,C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,estramustine,Estramustine,,HIGH,HIGH,4.97,-6.07,1
1433.0,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,indapamide,Indapamide,NCGC00018172-18,LOW,INACTIVE,2.52,-4.03,0
,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,,Pelitinib,NCGC00263103-02,MODERATE,HIGH,4.57,-4.78,1
4807.0,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,riociguat,Riociguat,NCGC00379065-03,LOW,INACTIVE,2.27,-3.79,0
1824.0,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,mizolastine,Mizolastine,,MODERATE,HIGH,3.51,-3.69,1
,O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,EPIGALLOCATECHIN-3-MONOGALLATE,,HIGH,HIGH,2.38,-3.8,1
,CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1,,CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1,,Coumaphos,,MODERATE,HIGH,4.5,-5.39,1
1893.0,Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,nelfinavir,Nelfinavir mesylate|Nelfinavir Mesylate,,HIGH,HIGH,4.61,-5.48,1
747.0,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,cyclandelate,Cyclandelate,,LOW,INACTIVE,3.79,-3.46,0
2716.0,CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(O)COc1cccc(C(F)(F)F)c1,,CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1,travoprost,Travoprost,,LOW,INACTIVE,4.0,-4.84,0
926.0,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,disopyramide,Disopyramide,,LOW,INACTIVE,3.21,-3.84,0
,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,,Azilsartan (TAK-536)|Azilsartan,,LOW,INACTIVE,4.33,-4.57,0
3253.0,COC1C(OC(=O)C=CC=CC=CC=CC(=O)O)CCC2(CO2)C1C1(C)OC1CC=C(C)C,,CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2,fumagillin,Fumagillin,,LOW,INACTIVE,4.61,-5.16,0
1291.0,C#CC1(O)C=CC2C3CCC4=CC(=O)CCC4C3CCC21CC,,C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,gestodene,Gestodene,NCGC00263565-06,LOW,INACTIVE,3.17,-4.73,0
,CN(Cc1ccccc1)C(=O)C(NC(=O)c1cc2cc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)ccc2n1C)c1ccccc1,,CN(Cc1ccccc1)C(=O)[C@H](NC(=O)c1cc2cc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)ccc2n1C)c1ccccc1,,,NCGC00538141-01,HIGH,HIGH,7.42,-6.87,1
,COc1ccc2c(c1)[nH]c1c(C)nccc12,,COc1ccc2c(c1)[nH]c1c(C)nccc12,,HARMINE,,LOW,INACTIVE,3.05,-3.54,0
4942.0,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,lenvatinib,Lenvatinib,NCGC00263198-07,MODERATE,HIGH,3.03,-4.84,1
,CCC(=O)OC1(C(=O)COC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CCC(=O)O[C@]1(C(=O)COC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,,Amelometasone,,LOW,MODERATE,2.69,-4.84,0
,Cc1c(Cl)c(=O)oc2cc(OP(=O)(OCCCl)OCCCl)ccc12,,Cc1c(Cl)c(=O)oc2cc(OP(=O)(OCCCl)OCCCl)ccc12,,Haloxon,,LOW,INACTIVE,3.4,-4.3,0
3294.0,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,iloperidone,Iloperidone,,LOW,MODERATE,4.26,-4.15,0
2740.0,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,trifluoperazine,Trifluoperazine hydrochloride,NCGC00013226-32,HIGH,HIGH,4.88,-4.67,1
,CCCSSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N,,CCCSS/C(CCO)=C(/C)N(C=O)Cc1cnc(C)nc1N,,Prosultiamine,,LOW,INACTIVE,2.0,-3.59,0
785.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,dasatinib,Dasatinib,NCGC00181129-08,MODERATE,HIGH,2.75,-4.58,1
3407.0,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1,,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1,oxetacaine,Oxethazaine,,LOW,INACTIVE,3.73,-4.66,0
,CC1CCC(C(=O)N(c2cc(C#CC(C)(C)C)sc2C(=O)O)C2CCC(O)CC2)CC1,,CC1CCC(C(=O)N(c2cc(C#CC(C)(C)C)sc2C(=O)O)C2CCC(O)CC2)CC1,,VX-222,NCGC00346532-01,MODERATE,HIGH,3.95,-5.0,1
1116.0,CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)cc(OC)c(C)c1C,,CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C,etretinate,Etretinate,,HIGH,HIGH,6.31,-5.94,1
900.0,Cc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,,Cc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,dimemorfan,Dimemorfan phosphate,,LOW,INACTIVE,4.02,-5.22,0
2026.0,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,oxyphencyclimine,Oxyphencyclimine hydrochloride,,LOW,INACTIVE,2.88,-3.79,0
1225.0,CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,fluticasone propionate,Fluticasone propionate,NCGC00179308-13,LOW,INACTIVE,3.7,-4.64,0
4357.0,CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(C(C)O)NC(=O)C(C(O)C(O)c5ccc(O)cc5)NC(=O)C5CC(O)CN5C(=O)C(C(C)O)NC4=O)cc3)cc2)cc1,,CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)C([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)C([C@@H](C)O)NC4=O)cc3)cc2)cc1,anidulafungin,Anidulafungin,,HIGH,HIGH,1.87,-4.31,1
2422.0,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,saquinavir,Saquinavir|Saquinavir Mesylate,,HIGH,HIGH,4.04,-5.43,1
1617.0,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1C2=Cc1ccc(Cl)cc1,,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1,lumefantrine,Lumefantrine,,HIGH,HIGH,8.34,-7.24,1
1642.0,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,mebeverine,Mebeverine hydrochloride,,LOW,INACTIVE,4.86,-5.17,0
,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,,Liarozole,NCGC00181034-04,MODERATE,HIGH,3.65,-4.23,1
4908.0,COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC,,COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC,acotiamide,Acotiamide hydrochlorid,,LOW,INACTIVE,3.12,-4.37,0
4686.0,CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C,,CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C,phenothrin,Phenothrin,,MODERATE,LOW,6.43,-5.24,1
,O=C([O-])CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,,O=C([O-])CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,,Lesinurad (sodium),,LOW,MODERATE,3.41,-4.71,0
5080.0,COC(=O)NC(C(=O)N1CCCC1c1nc(-c2ccc3c(c2)OC(c2ccccc2)n2c-3cc3cc(-c4c[nH]c(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)n4)ccc32)c[nH]1)C(C)C,,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)ccc32)c[nH]1)C(C)C,elbasvir,Elbasvir,,HIGH,HIGH,6.19,-5.3,1
,O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1,,O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1,,SB-415286,NCGC00015950-05,HIGH,HIGH,3.72,-4.78,1
,O=C(O)C1C2CCC(CC2)C1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,Pimodivir,,LOW,INACTIVE,3.08,-4.02,0
,O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O,,O=C(C[C@@H]1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O,,Halofuginone hydrochloride,,HIGH,HIGH,1.32,-3.57,1
1127.0,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(O)(C(F)(F)F)C(F)(F)F)CC(O)CC1O,,C=C1/C(=C/C=C2\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(O)(C(F)(F)F)C(F)(F)F)C[C@@H](O)C[C@@H]1O,falecalcitriol,Falecalcitriol,,HIGH,MODERATE,5.51,-5.43,1
4806.0,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,vortioxetine,Brintellix,NCGC00386237-01,LOW,INACTIVE,4.52,-4.92,0
2806.0,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)C(C(=O)O)C(C)C,,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C,valsartan,VALSARTAN|Valsartan,,MODERATE,HIGH,2.95,-4.28,1
312.0,O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,,O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,benperidol,Benperidol,,LOW,INACTIVE,3.52,-3.38,0
,C[N+]1(CC2COC(c3ccccc3)(c3ccccc3)O2)CCCCC1,,C[N+]1(CC2COC(c3ccccc3)(c3ccccc3)O2)CCCCC1,,Anacolin,,LOW,INACTIVE,1.25,-7.23,0
2100.0,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,perazine,Perazine,,MODERATE,HIGH,4.19,-3.75,1
536.0,CON=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C)CSC12)c1csc(N)n1,,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C)CS[C@H]12)c1csc(N)n1,cefetamet pivoxil,Cefetamet pivoxil HCl,,HIGH,LOW,2.04,-4.05,1
2201.0,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,piretanide,Piretanide,,LOW,INACTIVE,2.18,-3.6,0
326.0,CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1,,CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1,benzonatate,Benzonatate,,MODERATE,HIGH,2.09,-5.58,1
138.0,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,alprostadil,11?-Prostaglandin E1|Alprostadil,NCGC00016535-19,LOW,INACTIVE,3.0,-3.68,0
2436.0,CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,sertraline,Sertraline hydrochloride,NCGC00092386-26,LOW,INACTIVE,5.06,-6.33,0
,CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1,,CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1,,Pyriproxyfen,,LOW,INACTIVE,4.9,-4.3,0
1051.0,CCOC(=O)CCC(=O)OC1C(OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)OC(C)CC1N(C)C,,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,erythromycin ethyl succinate,ERYTHROMYCIN ETHYLSUCCINATE,,LOW,INACTIVE,2.95,-3.76,0
,COc1ccc(C2C(C#N)=C(N)OC3=C2C(=O)CC(c2cccc4ccccc24)C3)cc1,,COc1ccc(C2C(C#N)=C(N)OC3=C2C(=O)CC(c2cccc4ccccc24)C3)cc1,,UCPH 101,,HIGH,HIGH,4.21,-5.26,1
2776.0,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,,O=C(O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,trospium,Trospium chloride,,LOW,INACTIVE,2.86,-6.81,0
534.0,CON=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C=Cc3scnc3C)CSC12)c1csc(N)n1,,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(/C=C\c3scnc3C)CS[C@H]12)c1csc(N)n1,cefditoren pivoxil,Cefditoren (Pivoxil),,HIGH,HIGH,2.91,-4.67,1
3725.0,CCN(CC)CCOc1ccc2nc(N(C)C)sc2c1,,CCN(CC)CCOc1ccc2nc(N(C)C)sc2c1,dimazole,Diamthazole,,LOW,INACTIVE,3.57,-3.33,0
,CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1,,CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1,,ABBV-744,,HIGH,HIGH,3.99,-5.14,1
1641.0,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1,,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1,mebendazole,Mebendazole,NCGC00016806-17,HIGH,LOW,2.84,-3.87,1
378.0,CC(=C(CCOC(=O)c1ccccc1)SSC(CCOC(=O)c1ccccc1)=C(C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N,,C/C(=C(/CCOC(=O)c1ccccc1)SS/C(CCOC(=O)c1ccccc1)=C(\C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N,bisbentiamine,Bisbentiamine,,MODERATE,HIGH,4.04,-5.17,1
3277.0,CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1,,CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1,hexetidine,Hexetidine,,LOW,MODERATE,4.98,-4.75,0
3615.0,Cc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCC3)c1,,Cc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCC3)c1,tolindate,Tolindate,,LOW,INACTIVE,4.64,-5.57,0
2376.0,COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O,,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,rifabutin,Rifabutin,NCGC00090762-05,HIGH,HIGH,4.17,-4.71,1
1829.0,COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1,,COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1,mofezolac,Mofezolac,,LOW,INACTIVE,3.56,-3.84,0
1517.0,CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)N1,,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1,ixabepilone,Ixabepilone,NCGC00378665-03,LOW,INACTIVE,3.28,-5.16,0
,CCCCCCC=CCCCCCCCC(=O)O,,CCCCCC/C=C\CCCCCCCC(=O)O,,9(Z)-Hexadecenoic acid,,HIGH,HIGH,6.71,-5.76,1
2068.0,Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1,,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,paroxetine,Paroxetine,,LOW,INACTIVE,3.1,-4.59,0
2107.0,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,periciazine,PERICIAZINE,,MODERATE,HIGH,3.78,-3.79,1
,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,,Mocetinostat,,MODERATE,LOW,3.01,-4.67,1
2828.0,CCOC(=O)C1=CC2(CC)CCCN3CCc4c(n1c1ccccc41)C32,,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32,vinpocetine,Vinpocetine,,MODERATE,HIGH,4.34,-4.14,1
5233.0,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,brigatinib,Brigatinib,,LOW,MODERATE,5.11,-4.43,0
450.0,Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1,,Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1,butoconazole,Butoconazole nitrate,NCGC00179596-11,HIGH,HIGH,6.71,-5.7,1
1942.0,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],nisoldipine,Nisoldipine,,HIGH,HIGH,3.27,-4.84,1
4226.0,CC=C(C)C(=O)OC1C(C)=CC23C(=O)C(C=C(CO)C(O)C12O)C1C(CC3C)C1(C)C,,C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C,ingenol mebutate,Ingenol mebutate,NCGC00345812-03,LOW,MODERATE,2.48,-3.19,0
1201.0,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,flunisolide,Flunisolide,NCGC00179492-08,LOW,INACTIVE,2.2,-4.07,0
5.0,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)[C@H]1c1cccc([N+](=O)[O-])c1,(S)-nicardipine,Nicardipine,,HIGH,HIGH,4.34,-5.3,1
1451.0,CC(=O)N(CC(C)C(=O)O)c1c(I)cc(I)c(N)c1I,,CC(=O)N(CC(C)C(=O)O)c1c(I)cc(I)c(N)c1I,iocetamic acid,Iocetamic acid,,LOW,INACTIVE,3.15,-4.06,0
3580.0,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21,,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21,tamibarotene,Tamibarotene,NCGC00181111-05,MODERATE,HIGH,4.99,-5.79,1
,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,,Masitinib,"NCGC00241103-01, NCGC00241103-11",HIGH,HIGH,4.19,-5.24,1
,O=C(C=Cc1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl,,O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl,,Salubrinal,,HIGH,HIGH,4.9,-6.4,1
654.0,C(=Cc1ccccc1)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,cinnarizine,Cinnarizine,,HIGH,HIGH,5.19,-5.33,1
271.0,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,azelastine,Azelastine hydrochloride,,LOW,INACTIVE,3.8,-4.62,0
1867.0,N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1,,N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1,nafamostat,Nafamostat mesilate|NafamostatMesylate,"NCGC00160398-09, NCGC00389778-03",LOW,INACTIVE,1.91,-4.03,0
2237.0,O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1,,O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1,pranlukast,Pranlukast hydrate,,MODERATE,HIGH,4.56,-5.2,1
,Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C,,Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C,,Vadimezan,NCGC00165783-03,LOW,INACTIVE,3.05,-4.1,0
896.0,CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1,,CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1,diloxanide furoate,Diloxanide furoate,,LOW,INACTIVE,3.4,-3.93,0
1082.0,C#CC1(O)CCC2C3CCc4cc(O)ccc4C3CCC21C,,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,ethinylestradiol,Ethinylestradiol,NCGC00091533-17,LOW,LOW,3.63,-4.64,0
719.0,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,clotrimazole,Clotrimazole,,HIGH,HIGH,5.48,-5.36,1
4809.0,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,macitentan,Macitentan,NCGC00346456-07,MODERATE,LOW,3.02,-4.94,1
,O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(c3ccnc4cc(Cl)ccc34)CC2)c([N+](=O)[O-])c1,,O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(c3ccnc4cc(Cl)ccc34)CC2)c([N+](=O)[O-])c1,,VR23,,HIGH,HIGH,3.21,-4.79,1
1018.0,CCN(CC)C(=O)C(C#N)=Cc1cc(O)c(O)c([N+](=O)[O-])c1,,CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1,entacapone,Entacapone,,HIGH,HIGH,2.46,-3.58,1
,C=C(C)C1CCC2(C(=O)O)CCC3(C)C(CCC4C5(C)CCC(OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CCC43C)C12,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,,Bevirimat,,HIGH,HIGH,5.88,-6.65,1
1045.0,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,erlotinib,Erlotinib,NCGC00164574-14,HIGH,LOW,3.12,-4.64,1
2105.0,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,pergolide,Pergolide methanesulfonate,,LOW,MODERATE,4.17,-5.73,0
,COc1c2c(cc3c1-c1c(cc4c(c1OC)OCO4)CC(C)C(C)C3)OCO2,,COc1c2c(cc3c1-c1c(cc4c(c1OC)OCO4)C[C@@H](C)[C@@H](C)C3)OCO2,,Schisandrin C,,MODERATE,LOW,4.01,-4.37,1
,COP(=S)(OC)Oc1ccc(SC)c(C)c1,,COP(=S)(OC)Oc1ccc(SC)c(C)c1,,Fenthion,,LOW,INACTIVE,3.93,-4.82,0
1627.0,CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1,,CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1,malotilate,Malotilate,NCGC00164588-06,LOW,INACTIVE,3.58,-3.8,0
1302.0,COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C,,COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C,gliquidone,Gliquidone,,MODERATE,HIGH,3.57,-5.38,1
1969.0,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,normethadone,Normethadone,,LOW,INACTIVE,3.84,-4.6,0
4192.0,O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,,O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,tafamidis,Tafamidis,,MODERATE,LOW,3.91,-3.98,1
,CC(=O)ON=C1C(=O)N(Cc2cc(Cl)ccc2Cl)c2ccc(Cl)cc21,,CC(=O)O/N=C1\C(=O)N(Cc2cc(Cl)ccc2Cl)c2ccc(Cl)cc21,,LDN-57444,,HIGH,HIGH,4.42,-5.65,1
1643.0,CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1,,CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1,mebhydrolin,MEBHYDROLIN,,LOW,INACTIVE,3.7,-3.88,0
4890.0,OCC1OC(c2ccc(F)c(Cc3cc4ccccc4s3)c2)C(O)C(O)C1O,,OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O,ipragliflozin,Ipragliflozin,,LOW,INACTIVE,2.49,-4.13,0
734.0,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,cortisone acetate,Cortisone acetate,NCGC00021191-15,LOW,INACTIVE,2.35,-4.16,0
5252.0,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,neratinib,Neratinib,NCGC00241101-10,LOW,MODERATE,4.72,-4.91,0
,CC1C2CCC3C4CC=C5CC(N(C)C)CCC5(C)C4CCC32CN1C,,C[C@H]1[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](N(C)C)CC[C@]5(C)[C@H]4CC[C@]23CN1C,,Conessine,,LOW,INACTIVE,4.47,-5.06,0
4973.0,Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)C=Cc2cccnc2)cc1,,Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1,chidamide,Chidamide,NCGC00263598-06,LOW,LOW,2.55,-5.22,0
4758.0,Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,,Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,canagliflozin,Canagliflozin,NCGC00346691-07,LOW,INACTIVE,3.14,-4.99,0
1364.0,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,hexachlorophene,Hexachlorophene,,HIGH,HIGH,6.77,-5.97,1
,COCC(=O)Nc1cc(Sc2ccccc2)ccc1N=C(NC(=O)OC)NC(=O)OC,,COCC(=O)Nc1cc(Sc2ccccc2)ccc1N=C(NC(=O)OC)NC(=O)OC,,Febantel,,LOW,INACTIVE,2.69,-4.93,0
2495.0,Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,,Clc1ccc(CS[C@@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,sulconazole,Sulconazole nitrate,,HIGH,HIGH,5.78,-5.49,1
1212.0,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,fluphenazine,Fluphenazine hydrochloride,NCGC00015436-14,HIGH,HIGH,4.4,-4.36,1
2353.0,Cc1nc2ccc(CN(C)c3ccc(C(=O)NC(CCC(=O)O)C(=O)O)s3)cc2c(=O)[nH]1,,Cc1nc2ccc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)cc2c(=O)[nH]1,raltitrexed,Raltitrexed,NCGC00229704-02,LOW,INACTIVE,1.79,-4.4,0
,Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O,,Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O,,Closantel,,HIGH,HIGH,6.37,-5.63,1
836.0,COC(=O)C(c1ccccc1)C1CCCCN1,,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1,dexmethylphenidate,METHYLPHENIDATE HYDROCHLORIDE,,LOW,INACTIVE,1.46,-3.11,0
3972.0,CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2,,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,ivermectin,Ivermectin,,HIGH,HIGH,4.37,-5.15,1
1917.0,O=C(OCC1(COC(=O)c2cccnc2)CCCC(COC(=O)c2cccnc2)(COC(=O)c2cccnc2)C1O)c1cccnc1,,O=C(OCC1(COC(=O)c2cccnc2)CCCC(COC(=O)c2cccnc2)(COC(=O)c2cccnc2)C1O)c1cccnc1,nicomol,Nicomolol,,MODERATE,HIGH,1.97,-4.61,1
863.0,Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O,,Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O,dichlorophen,Dichlorophen,,HIGH,HIGH,3.92,-3.94,1
1616.0,CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12,,CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12,lucanthone,Lucanthone,,HIGH,HIGH,4.73,-5.03,1
,COc1ccc2cc1Oc1ccc(cc1)CC1c3c(cc4c(c3Oc3cc5c(cc3OC)CCN(C)C5C2)OCO4)CCN1C,,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3c(cc4c(c3Oc3cc5c(cc3OC)CCN(C)[C@@H]5C2)OCO4)CCN1C,,Cepharanthine,,HIGH,HIGH,5.32,-5.1,1
230.0,CC(OC1OCCN(Cc2n[nH]c(=O)[nH]2)C1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,aprepitant,Aprepitant,NCGC00181785-01,MODERATE,HIGH,2.43,-4.46,1
,O=C(O)C(S)=Cc1c[nH]c2ccc(F)cc12,,O=C(O)/C(S)=C/c1c[nH]c2ccc(F)cc12,,PD-151746,,HIGH,HIGH,2.75,-3.87,1
4902.0,Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1,,Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1,imidafenacin,Imidafenacin,,LOW,INACTIVE,2.81,-4.52,0
1175.0,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,flavoxate,Flavoxate hydrochloride,,LOW,INACTIVE,3.64,-4.41,0
,CC(C)(CNC(=O)c1cccc(-c2noc(C(F)(F)F)n2)c1)c1coc(-c2ccccc2)n1,,CC(C)(CNC(=O)c1cccc(-c2noc(C(F)(F)F)n2)c1)c1coc(-c2ccccc2)n1,,TMP195,NCGC00386712-01,LOW,INACTIVE,5.04,-4.58,0
,O=C(CCCN1CCC(C(=O)c2ccc(F)cc2)CC1)c1ccc(F)cc1,,O=C(CCCN1CCC(C(=O)c2ccc(F)cc2)CC1)c1ccc(F)cc1,,Lenperone Hydrochloride,,LOW,INACTIVE,3.93,-4.96,0
593.0,CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,,CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,chlorcyclizine,Chlorcyclizine,,LOW,INACTIVE,4.16,-3.85,0
280.0,CCOC(=O)OC(C)OC(=O)C1N2C(=O)C(NC(=O)C(N)c3ccccc3)C2SC1(C)C,,CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C,bacampicillin,Bacampicillin hydrochloride,,LOW,INACTIVE,1.17,-3.58,0
1551.0,CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1,,CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,latanoprost,Latanoprost,,LOW,INACTIVE,4.16,-4.57,0
2501.0,COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,,COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,sulfadimethoxine,Sulfadimethoxine,,LOW,INACTIVE,1.09,-3.05,0
5222.0,NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12,,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,niraparib,MK-4827|Niraparib,,LOW,INACTIVE,2.45,-4.33,0
2781.0,COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3N(C)CC2)CC[N+]1(C)C,,COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C,tubocurarine,(+)-Tubocurarine chloride hydrochloride,,LOW,INACTIVE,3.12,-6.3,0
,COCCNC(=O)Nc1ccc2nc(-c3cccs3)c(-c3cccs3)nc2c1,,COCCNC(=O)Nc1ccc2nc(-c3cccs3)c(-c3cccs3)nc2c1,,,NCGC00411883-01,MODERATE,HIGH,4.19,-4.64,1
3309.0,Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1,,Clc1ccc([C@H](Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1,isoconazole,Isoconazole nitrate,NCGC00179642-05,HIGH,HIGH,5.86,-5.7,1
3032.0,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,bithionol,Bithionol,,HIGH,HIGH,6.12,-5.33,1
2451.0,CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C,,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C,sitosterol,Angelicin,NCGC00142598-07,LOW,INACTIVE,7.24,-7.35,0
2279.0,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,progesterone,Progesterone,NCGC00015785-10,LOW,INACTIVE,3.58,-4.76,0
2720.0,CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21,,CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,treprostinil,,NCGC00319020-01,LOW,HIGH,3.53,-4.74,0
,C=C1CCCC2(C)Cc3occ(C)c3CC12,,C=C1CCC[C@]2(C)Cc3occ(C)c3C[C@@H]12,,Atractylon,,HIGH,HIGH,4.21,-4.11,1
,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C1c1cccc([N+](=O)[O-])c1,,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C1c1cccc([N+](=O)[O-])c1,,Watanidipine,,HIGH,HIGH,6.78,-6.66,1
,NC(N)=NCc1cccc(I)c1,,NC(N)=NCc1cccc(I)c1,,MIBG,,LOW,INACTIVE,1.53,-3.5,0
,Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1,,Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1,,TMC353121,,HIGH,HIGH,4.56,-4.7,1
2352.0,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,raltegravir,Raltegravir|Raltegravir Potassium,NCGC00167356-11,LOW,MODERATE,1.3,-3.66,0
,CCCCCCCCCCCCOC(=O)CS(=O)(=O)[O-],,CCCCCCCCCCCCOC(=O)CS(=O)(=O)[O-],,SODIUM LAURYL SULFOACETATE,,MODERATE,LOW,2.33,-4.73,1
,CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2n1CC(=O)O,,CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2n1CC(=O)O,,TMCB,,LOW,INACTIVE,4.28,-4.44,0
,O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,,O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,,OXANTEL PAMOATE,,HIGH,HIGH,4.4,-4.97,1
1465.0,CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O,,CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O,iopanoic acid,Iopanoic acid,,MODERATE,HIGH,3.93,-4.62,1
2797.0,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,ursodiol,Ursodiol,"NCGC00142400-07, NCGC00179363-05",LOW,MODERATE,3.01,-4.3,0
258.0,O=C1C(O)=C(C2CCC(c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21,,O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21,atovaquone,Atovaquone|ATOVAQUONE,,HIGH,HIGH,4.72,-5.66,1
,CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O,,CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O,,Tyrphostin A9,,MODERATE,HIGH,5.5,-4.7,1
4187.0,CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,crizotinib,(S)-Crizotinib,NCGC00250400-05,HIGH,HIGH,3.82,-4.86,1
,Cc1[nH]cnc1CC1CCc2c(C)c3ccccc3n2C1=O,,Cc1[nH]cnc1C[C@H]1CCc2c(C)c3ccccc3n2C1=O,,Fabesetron,,HIGH,HIGH,3.29,-4.04,1
1873.0,COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1,,COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1,naftopidil,Naftopidil,NCGC00015718-24,LOW,MODERATE,3.65,-3.75,0
1469.0,CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I,,CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I,iotalamic acid,Iothalamate sodium,,LOW,INACTIVE,2.27,-3.7,0
,CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1,,CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1,,PIK-93,NCGC00346536-06,LOW,INACTIVE,1.48,-4.09,0
868.0,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,dicycloverine,Dicyclomine,,LOW,INACTIVE,5.82,-4.98,0
1832.0,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,mometasone furoate,Mometasone furoate,NCGC00179578-11,HIGH,HIGH,4.27,-4.68,1
4673.0,CN(C(=O)C=Cc1ccoc1)C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,,CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,nalfurafine,Nalfurafine hydrochloride,,LOW,INACTIVE,3.29,-3.47,0
3096.0,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O,cholic acid,Cholic Acid,,MODERATE,MODERATE,2.26,-3.77,1
2429.0,C#CCN(C)C(C)Cc1ccccc1,,C#CCN(C)[C@H](C)Cc1ccccc1,selegiline,Selegiline hydrochloride,NCGC00024994-12,LOW,INACTIVE,3.05,-3.87,0
2571.0,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,tazarotene,Tazarotene,NCGC00167525-11,LOW,MODERATE,5.15,-5.67,0
4292.0,Cc1ccc(C=C2C(=O)C3(C)CCC2C3(C)C)cc1,,Cc1ccc(/C=C2/C(=O)C3(C)CCC2C3(C)C)cc1,enzacamene,ENZACAMENE,,MODERATE,HIGH,5.09,-4.7,1
,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1,,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1,,Genkwanin,,HIGH,HIGH,3.39,-3.71,1
4870.0,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=Cc1ccc(-c2cccc(F)c2)cn1,,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1,vorapaxar,Vorapaxar Sulfate,NCGC00263108-02,HIGH,HIGH,5.0,-5.88,1
3123.0,CC1CCCCN1CCCOC(=O)c1ccc(OC2CCCCC2)cc1,,CC1CCCCN1CCCOC(=O)c1ccc(OC2CCCCC2)cc1,cyclomethycaine,Cyclomethycaine,,LOW,INACTIVE,5.57,-5.26,0
5014.0,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,brexpiprazole,Brexpiprazole,,HIGH,HIGH,5.38,-5.29,1
,COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1,,COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1,,CUDC-907,NCGC00346692-03,HIGH,HIGH,2.62,-4.52,1
2534.0,CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc(S(C)=O)cc1,,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1,sulindac,Sulindac,NCGC00015970-10,MODERATE,LOW,2.96,-4.15,1
1527.0,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,ketoconazole,Ketoconazole,NCGC00025000-22,HIGH,HIGH,4.3,-4.75,1
,O=C(Nc1ccccc1F)NC1N=C(c2ccccc2)c2ccccc2NC1=O,,O=C(Nc1ccccc1F)N[C@@H]1N=C(c2ccccc2)c2ccccc2NC1=O,,RSV604 (R enantiomer),,MODERATE,HIGH,3.06,-4.84,1
